Centrexion Therapeutics

Centrexion

Centrexion develops non-opioid, non-addictive therapies for the treatment of chronic pain and autoimmune diseases for patients with unmet medical needs.

Latigo Biotherapeutics

This clinical-stage biopharmaceutical company develops non-opioid medicines to treat patients suffering from pain without the risk of addiction.

Mimetic Medicines

This company develops non-opioid peptide drug candidates for patients suffering from chronic pain.

Latigo

This clinical-stage biopharmaceutical company develops non-opioid medicines to treat acute and chronic pain for patients needing alternatives to addictive painkillers.

CeNeRx

This biopharmaceutical company develops clinical-stage therapeutics for central nervous system disorders, such as depression and pain, for patients and healthcare providers.

Aptinyx

This biopharmaceutical company develops small-molecule modulators of NMDA receptors to treat patients with chronic pain and central nervous system disorders.

Brixton Biosciences

This life sciences company develops a nerve-selective injectable biomaterial that provides long-lasting, drug-free pain relief for patients suffering from chronic and acute orthopedic conditions.

Synerkine Pharma

This company develops fusion protein therapeutics to treat chronic pain and peripheral neuropathy for patients with inflammatory and neurodegenerative conditions.